UQ Centre for Cardiac and Vascular Biology Research Affiliates
We are dedicated to generating fundamental knowledge in cardiovascular biology that can be translated into clinical progress. To achieve this, we collaborate with clinicians and researchers around Australia and Internationally. Our major research affiliates are listed below.
Professor John F. Fraser, MB ChB, PhD, FRCP (Glasgow), FFARCSI, FRCA, FCICM
Director, Intensive Care Unit, St Andrews War Memorial Hospital
Director, Critical Care Research Group, The Prince Charles Hospital
Professor and Pre-Eminent Specialist in Intensive Care Medicine, The Prince Charles Hospital
Professor Anaesthesiology and Critical Care School of Medicine, The University of Queensland
Professor of Medicine, Bond Univeristy
Adjunct Professor, Queensland University of Technology
Adjunct Professor, Monash University
Associate Professor School of Medicine, Griffith University
Professor John Fraser is a graduate of the University of Glasgow where he received fellowships in Medicine and Anaesthesia during his basic ICU training. He arrived in Australia in a second hand kilt via Russia, Mongolia and China via the Trans Siberian Railway. He completed his ICU training in Brisbane prior to his PhD on burns and smoke inhalation injury through University of Queensland. He is a pre-eminent Intensivist at The Prince Charles Hospital, where he founded and heads the multi disciplinary Critical Care Research Group, the largest group of its kind in Australasia. He is the Director of ICU at St Andrew’s War Memorial Hospital, Brisbane, and has 5 professorial appointments. Professor Fraser currently supervises over 20 PhD, MPhil and honours students in medicine, surgery, basic science, engineering and allied health fields across 7 laboratories. Since the inception of CCRG in 2004, the group has earned more than $29 million dollars (AUD) in grants and industry funding. He has published over 250 peer-reviewed papers and multiple book chapters. In 2014 the group was awarded The Centre for Research Excellence (one of only of six clinical CRE’s) in Australasia looking at the development and utilisation of bionic hearts and lungs, collaborating throughout Australia, Japan, Singapore, Malaysia and China. Professor Fraser was the co-founder and chief medical officer of BiVACOR, a total artificial heart and the Medical Director for the Innovative Cardiovascular Engineering Laboratory (www.bivacor.com and www.icetlab.com). He is the proud father of 5 great children and is supported by the beautiful Katrina, who says she has six children!
Associate Professor John Atherton
Director of Cardiology, Royal Brisbane and Women’s Hospital
Associate Professor, Department of Medicine, The University of Queensland
Adjunct Professor, Queensland University of Technology
Pre-eminent Staff Specialist, Queensland Health
Dr John Atherton is Director of Cardiology (Royal Brisbane and Women's Hospital). He has sat on the Board of the Cardiac Society of Australia and New Zealand (CSANZ) and chaired the CSANZ Professional Ethics Standards Committee. He chaired the CSANZ Heart Failure Council and the Asia-Pacific Acute Decompensated Heart Failure (HF) Registry Scientific Advisory Committee. He sat on the National Heart Foundation HF Guidelines executive writing group and was an official content reviewer for the 2016 ESC HF Guidelines. Clinical service and research interests include investigating methods to detect presymptomatic cardiac disease, heart failure disease management, clinical databases, and cardiac genetics.
Associate Professor Julie McGaughran, BSc (Hons) MB ChB (Hons) MD FRCP FRACP
Medical Director, Genetic Health QLD, Royal Brisbane and Women’s Hospital
Julie McGaughran is a clinical geneticist and Director of Genetic Health Queensland. She trained in clinical genetics in the UK and has also worked in New Zealand. She is a former president of the Human Genetics Society of Australasia and currently on the Board of the European Society of Human Genetics. She was a member of the Adult Medicine Division Council of the RACP for 5 years and a Board member of RACP. She is a member of the DOHA Genetics Working Party.
She has published in many areas of genetics and is a member of the editorial board of the American Journal of Medical Genetics and Cardiovascular Genetics and Genomics. She established the Queensland cardiac genetics clinic with Dr John Atherton in 2007.
Dr Joseph Powell, BSc MSc PhD
Group Leader, Genomics of Development and Disease Division, Institute for Molecular Bioscience, The University of Queensland
Joint appointment, Queensland Brain Institute, The University of Queensland
Since 2015 Joseph Powell has been the head of the Single Cell and Computational Genomics Lab at the University of Queensland’s Institute for Molecular Bioscience and an NHMRC Career Development Fellow. He obtained his Ph.D. from the University of Edinburgh in 2010 and subsequently completed a postdoctoral position in Peter Visscher’s (FAA) group at QIMR. In January 2014, he was appointed as a Team Leader at the Centre for Neurogenetics and Statistical Genomics, located at the University of Queensland. During this time he was instrumental in forming a large international consortium to study the genetic control of gene expression. In 2016 he was awarded the Commonwealth Health Minister Medal for Excellence in Medical Research and awarded an NHMRC prize for the top-ranked CDF applicant in 2015.
His research involves the use of large-scale transcriptomic and DNA sequence data from both bulk tissues and single cells, focusing on understanding the genetic mechanisms by which heritable variants contribute to disease susceptibility at a cellular level, and ultimately achieve therapeutic and diagnostic outcomes. His group consists of both a high-throughput single cell sequencing laboratory and a core of computational genomics expertise. In the past five years, he has published first/senior author papers in Nature, Nature Communications (x2), Genome Research (x2), American Journal of Human Genetics, Human Molecular Genetics and PLos Genetics.
Professor Glenn King, BSc, PhD, FAAM
NHMRC Principal Research Fellow
Professor and Group Leader, Chemistry and Structural Biology Division, Institute for Molecular Bioscience, The University of Queensland
Affiliate Professor SCMB, UQ
Investigator, Centre for Pain Research, IMB, UQ
Investigator, Breakthrough Science Program in Algal Biomedicine, IMB, UQ
Glenn graduated PhD from the University of Sydney before postdoctoral studies at the University of Oxford. After academic stints at University of Sydney and the University of Connecticut Health Center, he joined the IMB in 2007, where he is a NHMRC Principal Research Fellow. Glenn’s research is highly translational and focusses on development of drugs for treating neurological disorders such as stroke, chronic pain, and epilepsy. He has published one book, 21 book chapters, and more than 220 journal articles. Glenn is inventor on 12 patents and he founded Vestaron Corporation, a biotechnology company that is developing eco-friendly bioinsecticides discovered in his lab. He consults for several biotech companies and serves on numerous Scientific Advisory Boards and journal Editorial Boards. Glenn is passionate about mentorship and science communication, and he has appeared on numerous TV programs and documentaries.